BioWorld

May 2, 2003

View Archived Issues

124 Genes Of 9,600 Confirmed Four Permutations Of Two Cancer Drugs For Optimum Outcome

Read More

Epimmune Receives Boost From Merck Vaccine Deal

Read More

Other News To Note

Read More

Rib-X Raises $51M To Push Ribosome-Based Antibiotics

Rib-X Pharmaceuticals Inc. landed the year s third-largest private round of financing, reeling in $51 million in a Series B placement of preferred stock.(BioWorld Today) Read More

Galileo Gets $31M To Advance Internal, Partnered Programs

Read More